INOVIO PHARMACEUTICALS INC financial statements, including revenue, expenses, profit, and loss
The total revenue of GBM for the last quarter is 93.00 k EUR, and it's 74.69% lower compared to the previous quarter. The net income of Q4 23 is -22.65 M EUR.